Aprea Therapeutics's market cap is currently $15.44M. The company's EPS TTM is $-2.812; its P/E ratio is ―; Aprea Therapeutics is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $-0.66. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 583.23K	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ 576.18K	$ -186.44K	$ -271.68K	$ -229.61K	$ -170.25K
Operating Income	$ -15.47M	$ 38.18M	$ -38.04M	$ -52.15M	$ -31.04M
EBITDA	$ -14.28M	$ -112.48M	$ -36.86M	$ -53.25M	$ -27.89M
Net Income	$ -14.29M	$ -224.88M	$ -36.54M	$ -53.92M	$ -26.41M
Balance Sheet
Cash & Short-Term Investments	$ 21.61M	$ 28.79M	$ 53.08M	$ 89.02M	$ 130.09M
Total Assets	$ 22.65M	$ 30.16M	$ 56.82M	$ 92.81M	$ 133.61M
Total Debt	$ 0.00	$ 0.00	$ 190.47K	$ 335.16K	$ 544.95K
Net Debt	$ -21.61M	$ -28.79M	$ -52.89M	$ -88.68M	$ -129.54M
Total Liabilities	$ 5.70M	$ 4.51M	$ 7.32M	$ 15.41M	$ 9.36M
Stockholders' Equity	$ 18.26M	$ 25.64M	$ 49.51M	$ 77.40M	$ 124.24M
Cash Flow
Free Cash Flow	$ -12.27M	$ -25.01M	$ -37.69M	$ -41.83M	$ -26.74M
Operating Cash Flow	$ -12.18M	$ -25.01M	$ -37.69M	$ -41.80M	$ -26.71M
Investing Cash Flow	$ -93.09K	$ 0.00	$ 0.00	$ -25.71K	$ -30.90K
Financing Cash Flow	$ 5.14M	$ 682.97K	$ 1.75M	$ 150.95K	$ 92.58M

Currency in USD

Aprea Therapeutics Earnings and Revenue History

Income Statement >

Aprea Therapeutics Debt to Assets

Balance Sheet >

Aprea Therapeutics Cash Flow

Cash Flow >

Aprea Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing